What is the main business of Centrum Badawczo-Rozwojowe Novasome?

The main business activity of Centrum Badawczo-Rozwojowe Novasome focuses on research and experimental development in natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 14, 2005.

Where is the headquarters located?

The headquarters is located at: Olsztyńska 5, 51-423 Wrocław.

What is the share capital?

The share capital of the company is PLN 2,000,000 (approx. $540,249).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $2,913,009 in 2024, which is a decrease of 7.0% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $268,834, meaning the company decreased its profit by 55.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $1,018,034 in 2024, representing 41% of all operating expenses.

Centrum Badawczo-Rozwojowe Novasomesp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2005-01-14

Share capital

2 000 000,00 PLN

Registered address

Olsztyńska 5, 51-423 Wrocław, Poland

Electronic delivery address

AE:PL-87632-44307-EVWBU-20

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.16mMedianUSD 133.91kAverageUSD 4.65m

Net profit

This companyUSD 114.93kMedianUSD -54.78AverageUSD 310.10k

Operating costs

This companyUSD 2.92mMedianUSD 175.72kAverageUSD 4.46m

Assets

This companyUSD 7.64mMedianUSD 254.44kAverageUSD 8.12m

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-04-01. Active

Erste Bank Polska
91 1090 1522 0000 0001 3658 9456
Erste Bank Polska
51 1090 1522 0000 0001 0691 1183
Erste Bank Polska
54 1090 1522 0000 0001 0718 0110

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Buildings and premises	PLN 293.6KPLN 293,595

Public aid

5 public aid cases recorded, with a total value of $2,631,346.

Grant date	Purpose	Gross amount	Granting body
Jan 4, 2023	Aid for research and development projects: industrial research	$752.5K$752,457	Prezes Agencji Badań Medycznych
Sep 29, 2021	Aid for research and development projects: industrial research	$1.8M$1,841,554	Dyrektor Narodowego Centrum Badań i Rozwoju
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$12,406$12,406	Prezes Zakładu Ubezpieczeń Społecznych

European Funds

Start	Project	EU co-financing	Programme
2021-07-01	Opracowanie innowacyjnej linii pilotażowej i jej walidacja w warunkach rzeczywistych przy wykorzystaniu syntezy modelowej substancji czynnej	$1.5M$1,491,838	Program Operacyjny Inteligentny Rozwój
2016-10-01	Rozbudowa Centrum Badawczo-Rozwojowego NOVASOME Sp. z o.o. w celu opracowywania innowacyjnych projektów	$359.3K$359,335	Regionalny Program Operacyjny Województwa Dolnośląskiego 2014-2020

Tenders

No recorded participation in tenders.

Trademarks

Centrum Badawczo-Rozwojowe Novasome holds 5 active trademarks registered with the Polish Patent Office. The first mark was filed in 2007.

Mark	Number	Classes	Status	Protected until
CBR NOVASOME(word)	Z.352905	5, 35, 42, 44	Protected	Mar 4, 2029
NOVASOME(word)	Z.352904	5, 35, 42, 44	Protected	Mar 4, 2029
CENTRUM BADAWCZO-ROZWOJOWE NOVASOME(word)	Z.352906	5, 35, 42, 44	Protected	Mar 4, 2029
NOVASOME Centrum Badawczo-Rozwojowe	Z.326304	5, 42, 44	Protected	Jun 8, 2027
NOVASOME Centrum Badawczo-Rozwojowe	Z.326303	5, 42, 44	Protected	Jun 8, 2027

Mark	Protected until
CBR NOVASOME(word)	Mar 4, 2029
NOVASOME(word)	Mar 4, 2029
CENTRUM BADAWCZO-ROZWOJOWE NOVASOME(word)	Mar 4, 2029
NOVASOME Centrum Badawczo-Rozwojowe	Jun 8, 2027
NOVASOME Centrum Badawczo-Rozwojowe	Jun 8, 2027

Regulatory authorisations

Authority	Type	Status
BDO	Waste generation	Active

Authorized Representatives

Maciej Barys – Vice President of the Management Board

Beata Pepłowska – Attorney-in-fact (sole)

Tomasz Marcin Han – President of the Management Board

Manner of representation

The following persons are authorized to submit declarations of will and sign on behalf of the company: a) in the case of a one-person management board – the sole member of the management board independently; b) in the case of a multi-member management board – the President of the Management Board and each Vice-President independently, or any two members of the management board jointly.

Ownership

Owner	Shares	Stake
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco-lek S.A.	1,950	100%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Recepto Pharmasp. z o.o.	129,119.39 USD	27.9532%

Competitors

Name	Revenue	Website
Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju TechnologiiResearch institute	$23,627,462.01	port.lukasiewicz.gov.pl
XtplS.A.	$3,872,928.18	xtpl.com
Wills Innovationsp. z o.o.	$653,603.48	wills.pl
BioceltixS.A.	$616,315.97	bioceltix.com
OrthogetS.A.	$532,980.53	orthoget.com
Green ZebrasS.A.	$328,658.91	whygreenzebras.pl
BiocamS.A.	$327,799.68	biocam.ai
Ares Shield AiS.A.	$21,335.85	aresshield.ai
Captor TherapeuticsS.A.	–	captortherapeutics.pl
GMT GenomicsS.A.	–	genomtec.com

Change history

Date	Event
2020-01-23	PKD change (Removed: 68.20.Z, 82.30.Z; Added: 86.22.Z, 86.90.C)
2015-07-23	PKD change (Removed: 47.73.Z, 47.74.Z, 47.75.Z, 58, 72.1, 85.32.A, 85.32.B, 85.41.Z, 85.42.B, 85.60.Z, 86.90; Added: 72.19.Z)
2008-09-22	PKD change (Removed: 22.1, 24.41.Z, 24.42.Z, 52.3, 73, 73.10.B, 73.10.F, 73.10.H, 74.30.Z, 80.30.A, 80.30.C, 80.4, 85.14; Added: 20.59.Z, 21.10.Z, 21.20.Z, 47.73.Z, 47.74.Z, 47.75.Z, 58, 68.20.Z, 71.20, 72.1, 72.11.Z, 77.39.Z, 82.30.Z, 85.32.A, 85.32.B, 85.41.Z, 85.42.B, 85.59.B, 85.60.Z, 86.90)
2008-04-03	Share capital change (50,000.00 PLN → 2,000,000.00 PLN)
2008-04-03	PKD change (Added: 22.1, 80.30.A, 80.30.C, 80.4)

FAQ

Last updated: 2026-10-04